Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$5.09M Buy
24,547
+4,576
+23% +$902K 1.82% 12
2018
Q2
$3.69M Sell
19,971
-38,015
-66% -$6.72M 0.58% 48
2018
Q1
$9.88M Buy
57,986
+12,108
+26% +$2.22M 1.06% 8
2017
Q4
$7.98M Buy
45,878
+42,761
+1,372% +$7.57M 0.7% 31
2017
Q3
$581K Buy
3,117
+180
+6% +$31.9K 0.06% 274
2017
Q2
$506K Sell
2,937
-42,588
-94% -$6.93M 0.05% 406
2017
Q1
$7.47M Buy
+45,525
New +$7.56M 0.43% 43
2016
Q4
Sell
-9,596
Closed -$1.6M 800
2016
Q3
$1.6M Sell
9,596
-94,179
-91% -$15.9M 0.08% 339
2016
Q2
$15.8M Buy
103,775
+85,960
+483% +$13.4M 0.69% 20
2016
Q1
$2.67M Buy
+17,815
New +$2.65M 0.16% 186
2015
Q4
Sell
-15,075
Closed -$2.08M 744
2015
Q3
$2.08M Buy
15,075
+12,782
+557% +$2.01M 0.2% 154
2015
Q2
$352K Sell
2,293
-1,959
-46% -$314K 0.05% 444
2015
Q1
$680K Buy
4,252
+323
+8% +$50.9K 0.18% 166
2014
Q4
$626K Buy
3,929
+626
+19% +$97.5K 0.2% 173
2014
Q3
$464K Sell
3,303
-1,509
-31% -$197K 0.19% 177
2014
Q2
$570K Buy
+4,812
New +$557K 0.28% 100
2014
Q1
Sell
-3,164
Closed -$361K 331
2013
Q4
$361K Sell
3,164
-1,756
-36% -$200K 0.12% 202
2013
Q3
$551K Buy
+4,920
New +$533K 0.17% 164

Other funds holding AMGN

Clinton Group's AMGN Position: Q3 2018 in Review

Clinton Group increased its Amgen (AMGN) stake by 23% in Q3 2018, buying an estimated $902K and bringing the position to 24,547 shares worth $5.09M. The position accounts for 1.82% of the portfolio, ranked #12.

Clinton Group first reported a position in AMGN in Q3 2013 and has held it in 18 quarters since. The position peaked at $15.8M in Q2 2016. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

  • Clinton Group held 24,547 shares of Amgen worth $5.09M as of Q3 2018.
  • Clinton Group bought 4,576 Amgen shares in Q3 2018, an estimated $902K.
  • Amgen made up 1.82% of Clinton Group's portfolio in Q3 2018, its #12 holding.
  • Clinton Group first reported a position in Amgen in Q3 2013 and has held it in 18 quarters since.
  • Clinton Group's Amgen position peaked at $15.8M in Q2 2016.
  • 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.